Abstract
Measles virus infection induces a profound immunosuppression that may lead to serious secondary infections and mortality. In this report, we show that the human cortical thymic epithelial cell line is highly susceptible to measles virus infection in vitro, resulting in infectious viral particle production and syncytium formation. Measles virus inhibits thymic epithelial cell growth and induces an arrest in the G0/G1 phases of the cell cycle. Moreover, we show that measles virus induces a progressive thymic epithelial cell differentiation process: attached measles virus-infected epithelial cells correspond to an intermediate state of differentiation while floating cells, recovered from cell culture supernatants, are fully differentiated. Measles virus-induced thymic epithelial cell differentiation is characterized by morphological and phenotypic changes. Measles virus-infected attached cells present fusiform and stellate shapes followed by a loss of cell-cell contacts and a shift from low- to high-molecular-weight keratin expression. Measles virus infection induces thymic epithelial cell apoptosis in terminally differentiated cells, revealed by the condensation and degradation of DNA in measles virus-infected floating thymic epithelial cells. Because thymic epithelial cells are required for the generation of immunocompetent T lymphocytes, our results suggest that measles virus-induced terminal differentiation of thymic epithelial cells may contribute to immunosuppression, particularly in children, in whom the thymic microenvironment is of critical importance for the development and maturation of a functional immune system.
The primary causes of infant death in developing countries are associated with measles virus (MV) and human immunodeficiency virus (HIV) infection. Both infections result in the development of profound immunosuppression that contributes to secondary infections and mortality (4, 11, 18, 27). The dysfunction of the immune system in HIV patients is dramatic and ultimately fatal, whereas MV-induced immunosuppression is transitory. The physiological mechanisms involved in MV-induced immunodepression are still not well understood. The first indication of MV-induced immunosuppression is a transient unresponsiveness to tuberculin that is observed for several weeks after recovery from MV infection (47). Furthermore, in vitro stimulation of lymphocytes by mitogens (26, 35) or alloantigens (15) is suppressed after MV infection, and cytokine production has been shown to be abnormal as well (14, 22, 39, 48). Suppression of antibody synthesis as well as natural killer cell activity was reported in different in vitro and in vivo models (7, 19, 43, 50). Infection of dendritic cells with MV leads to a rapid up-regulation of activation markers, indicating their functional maturation in vitro (39). As a result, MV-infected dendritic cells suppressed mitogen-dependent proliferation of uninfected peripheral blood lymphocytes or T cells (14, 20, 39). Finally, it has been demonstrated that MV could induce apoptosis of infected cells and noninfected lymphocytes after their contact with infected cells in vitro (1, 9, 14).
Measles virus, belonging to the Paramyxoviridae family and the Morbillivirus genus, is an enveloped nonsegmented-strand RNA virus. Infection with MV is initiated by interaction of viral hemagglutinin (H) protein with the cellular receptor, the CD46 molecule, initially described as the membrane cofactor protein (8, 16, 30). This attachment is followed by virus-cell fusion, release of nucleocapsids into the cytoplasm, and expression of H and fusion (F) glycoproteins at the cell surface. During infection, CD46 is down-regulated concomitantly with the appearance of MV H protein on the cell surface (24, 30, 37). MV initially replicates in the respiratory tract and then spreads to local lymphoid tissue, where virus replication can occur in macrophages and/or in dendritic cells (10, 14, 20). This secondary viremia allows the spreading of the virus to other lymphoid organs, such as the thymus, liver, skin, and conjunctive tissues (6, 29, 49). Thymic stromal cells have been described as a target for MV in the SCID-hu mouse model after direct intrathymic inoculation of MV. As a result, MV replication in the thymic epithelial cells (TEC) as well as monocytes/macrophages leads to induction of thymocyte apoptosis (3, 45). Similarly, TEC were shown to be prominent targets of HIV and human cytomegalovirus infection, where infection of thymic epithelium is associated with profound thymic injury (2, 5, 28, 40, 41).
TEC play a critical role in the development and maturation of immunocompetent T cells, providing a microenvironment with a unique capacity to generate a functional and diverse T-cell repertoire (21). Thus, the interaction of virus with the thymic microenvironment may result in an alteration in the development of functional T cells. In this study, we demonstrate that MV infection induces terminal differentiation of TEC which is characterized by the arrest of proliferation and by morphological and phenotypic changes typical of epithelial cell maturation, followed by apoptosis of fully differentiated TEC. These results suggest that MV-induced terminal differentiation of TEC may contribute to a long-term immune dysfunction, particularly in infants, in whom ontogenesis of the immune system requires a functional thymic microenvironment.
MATERIALS AND METHODS
Cell culture, MV infection, and viral titration.
The previously described (12) P1.4D6 cortical TEC clone from human postnatal thymus was used. TEC were cultured in RPMI 1640 (Gibco Life Technologies, Inc., Grand Island, N.Y.) supplemented with 2 mM l-glutamine (Gibco Life Technologies), 10 mM HEPES (Gibco Life Technologies), 40 μg of gentamicin (Schering-Plough)/ml, and 10% fetal calf serum (Gibco Life Technologies). TEC were subcultivated at low density before infection, and attached TEC (3 × 103 cells/cm2 in 25 ml of culture medium) were infected with 1 PFU/cell of Vero-cell-derived infectious MV Hallé strain over a 2-h period, followed by three extensive washes. (These cells will be referred to hereafter as MV-TEC.) As a control, medium or MV inactivated by UV light over 30 min at 254 nm (UV-MV-TEC) was used. This MV strain has been classified as the vaccine MV Edmonston-like strain (34). Production of infectious MV particles from cell-free supernatant cultures was measured at different time points after infection on a highly permissive Vero cell monolayer where infectious-MV particles had formed lytic plaques. Less than 24 h before each experiment, cell supernatants from MV-TEC were removed. Attached TEC were collected after treatment with 1 mM EDTA.
Cytofluorometry analysis.
The monoclonal antibodies (MAbs) used were clone MCI20.6 (CD46; immunoglobulin G1 [IgG1] isotype [31]), clone 55 (anti-H; IgG2b isotype [17]), clone 120 (anti-nucleoprotein [NP]; IgG2b isotype [17]), clone Y503 (anti-F) (kindly provided by F. Wild [Lyon, France]), CAM5.2 (IgG2b isotype [Becton Dickinson, Mountain View, Calif.]), and AE3 (IgG1 isotype [Diagnostic Biosystems, Fremont, Calif.]). These latter two MAbs recognize keratin polypeptides of low (43 and 50 kDa) and high (58 and 65 to 67 kDa) molecular masses, respectively. Mouse IgG1 and IgG2b isotypic controls (Immunotech, Marseille, France) were used as negative controls of immunofluorescence.
For the detection of cell surface H and F viral proteins and CD46 molecules, immunofluorescence assays were performed as previously described (44), using biotinylated mouse antibody followed by streptavidin conjugated to R-phycoerythrin (Caltag Laboratories, Santa Cruz, Calif.). Intracellular antigens were detected after treatment of cells with 0.33% saponin (Sigma Chemical Co., St. Louis, Mo.) at 4°C for 30 min. Permeabilized cells were incubated with biotinylated anti-NP antibody and were labeled with streptavidin conjugated to R-phycoerythrin.
Dual immunofluorescence labeling was performed after cell permeabilization with saponin. Briefly, cells were stained with mouse anti-cytokeratin CAM5.2 or AE3 MAb followed by incubation with fluorescein isothiocyanate (FITC)-conjugated anti-mouse Ig (Jackson ImmunoResearch Laboratories, West Grove, Pa.). FITC-labeled cells were then stained with mouse biotinylated clone 120 (anti-NP) followed by incubation with streptavidin-phycoerythrin.
For cell cycle analysis, the attached P1.4D6 cells (5 × 105) were collected and fixed with 70% ethanol in phosphate-buffered saline. Fixed cells were incubated for 30 min at room temperature with 100 μg of RNase (Sigma Chemical Co.)/ml followed by staining with 10 μg of propidium iodide (Boehringer Mannheim, Meylan, France)/ml. The cell DNA content was measured, and the relative percentages of cells in G0/G1 and S/G2M phases of the cell cycle were then determined.
To evaluate the mitochondrial transmembrane potential (ΔΨm), 5 × 105 cells were incubated with 3,3′-dihexyloxacarbocyanine [DIOC6(3)], a fluorescent dye (40 nM in phosphate-buffered saline; Molecular Probe, Inc., Eugene, Oreg.), for 15 min at 37°C before analysis. During apoptosis, an increase of fluorescence may first be observed, resulting in an increase in mitochondrial volume (ΔΨm) (46) and followed by a decrease of DIOC6(3) fluorescence, thus characterizing apoptosis (51).
Cells were analyzed with a FACScan flow cytometer (Becton Dickinson; Cellquest software). Integrated fluorescence was measured, and data was collected from at least 10,000 events.
Indirect immunofluorescence staining.
Cytospin preparations of 7 × 104 attached TEC were fixed in acetone for 10 min at 4°C. Briefly, immunofluorescence staining was performed by using a mouse anti-cytokeratin CAM5.2 or AE3 MAb. These MAbs were revealed with FITC-conjugated anti-mouse Ig. The cells were observed with a Zeiss microscope (Carl Zeiss Inc., Thornwood, N.Y.).
DNA fragmentation analysis.
DNA laddering was performed as described previously (23). Briefly, TEC monolayers (directly lysed in the flask) and floating MV-TEC were lysed at different time points after infection, with 0.5% Triton X-100, 5 mM Tris (pH 7.5), 20 mM EDTA, and 0.1 mg of proteinase K (Boehringer)/ml for 20 min on ice. The low-molecular-weight DNA was isolated by centrifugation at 13,000 × g for 10 min, extracted twice with phenol/chloroform, precipitated by ethanol, and resuspended in 10 mM Tris–1 mM EDTA (pH 8) containing 100 μg of RNase A/ml over a 2-h period at 37°C. DNA from attached (50 μg) and from floating (2.5 μg) TEC were separated by electrophoresis for 3 h on a 1.5% agarose gel in Tris-borate-EDTA buffer and visualized by staining with 0.1 μg of ethidium bromide (Boehringer Mannheim)/ml. The molecular weight standards were based on multiples of a 200-bp DNA ladder (Eurogentec).
Evaluation of cell death.
Nuclear morphology of TEC monolayers on Lab-Tek chamber slides (Miles Laboratories, Naperville, Ill.) or floating cells from supernatants was examined after staining with 10 μg of Hoechst 33342 (Sigma)/ml for 30 min at 37°C. After fixation with 1% formol, the cells were observed with a Zeiss microscope (Carl Zeiss Inc.). Nuclear fragmentation and marked condensation of the chromatin with reduction of nuclear size defined apoptotic cells.
Electron microscopy.
Pelleted cells were fixed for 1 h in 0.1 M sodium cacodylate buffer containing 1% glutaraldehyde and 0.5% paraformaldehyde (final concentration). Postfixation was done in the same buffer containing 1% osmium tetroxide. The fixed and dehydrated pellets were embedded in Epon resin. Ultrathin sections were successively stained with methanolic uranyl acetate and lead citrate. Electron micrographs were taken with a Philips CM 120 electron microscope at the Electron Microscopy Center of the University of Lyon.
RESULTS
TEC are susceptible to MV infection in vitro.
The ability of human TEC to produce infectious viral particles was measured by assaying the culture supernatant for PFU at different time points after infection (Fig. 1). MV infection of TEC was productive and reached a peak at day 5 postinfection (4.09 ± 0.04 log10 PFU/ml) (Fig. 1A) with syncytium formation in less than 10% of infected TEC layers (see Fig. 5B and data not shown). In contrast, no MV production or syncytium formation was detected in cultures of TEC exposed to UV-inactivated MV (see Fig. 5B).
FIG. 1.
In vitro MV replication in human TEC. TEC were infected with MV Hallé strain (1 PFU per cell). (A) Kinetics of viral particle production in cell-free supernatants of MV-TEC. The number of PFU is expressed as the mean ± the standard deviation of five individual experiments. (B) Kinetics of MV proteins expression using cytofluorometry analysis. TEC cultures were analyzed at different time points after infection for the expression of membrane (H and F) or intracellular (NP) MV-specific proteins. Results are representative of five distinct experiments in which the standard deviations were less than 15%. (C) Down-regulation of CD46 molecule on MV-TEC at day 5 postinfection. ----, uninfected TEC; ——, UV-MV-TEC; ——————, MV-TEC. (Histogram profiles for uninfected cells and UV-MV-TEC are totally superimposed and therefore indistinguishable [right].) Fluorescence profiles are shown as histograms of cells labeled with MAbs. The dark histogram at left shows results of a negative control corresponding to the staining by an irrelevant MAb of an isotype identical to that of the specific MAb. Results are representative of six different experiments.
FIG. 5.
MV infection induced apoptosis in TEC cultures. In all experiments, more than 90% of attached TEC excluded propidium iodide, and more than 90% of floating cells incorporated it in MV-TEC cultures, as determined by cytofluorometry. (A) Electrophoresis of low-molecular-weight DNA from attached and floating TEC cultures at different time points. DNA from TEC cultures were extracted as described in Materials and Methods. (B) Nuclear fragmentation in syncytia of MV-TEC monolayers and condensation in differentiated floating MV-TEC cultures at day 5 postinfection, after Hoechst staining. Data are representative of four different experiments. The white arrow indicates syncytia, and the white scale bar represents 15 μm.
The ability of infected cells to produce F, H, and NP viral proteins and to down-regulate CD46 from the cell surface was analyzed by flow cytometry (Fig. 1B and C). Synthesis of all three viral proteins was detectable by 48 h after MV infection and increased gradually with time (Fig. 2B). More than 95% of TEC were infected by days 5 and 7 postinfection (data not shown). Down-regulation of MV receptor CD46 was observed (Fig. 1C) concomitantly with the appearance of viral H protein on the cell surface. In contrast, no modification of CD46 cell surface expression was detected in UV-MV-TEC compared to the uninfected TEC at day 5 postinfection (Fig. 1C).
FIG. 2.
Arrest of attached MV-TEC growth. (A) Kinetics of viable cells in attached TEC cultures. TEC were uninfected, treated with UV-MV, or infected with MV. The data are the means of at least three separate experiments. (B) Blocking MV-TEC in G0/G1 phases of the cell cycle as determined by propidium iodide staining and flow cytometry analysis, on days 1, 3, 5, and 7. In these experiments, control TEC cultures were at the same density as MV-TEC used in the same experiment. Blocking in G0/G1 phases of attached MV-TEC correlated with the progressive decrease in the number of infected cells in S/G2/M phases as indicated by percentages on the histograms. The data are percentages of cells in S/G2/M ± standard deviations from the mean of five different experiments. Statistical analysis was performed with the unpaired Student’s t test, and statistical significance in comparison with UV-MV-TEC levels of P < 0.05 (*) and P < 0.0001 (***) is shown.
Impaired growth of MV-TEC.
The consequence of MV replication on TEC growth was then analyzed by evaluating the number of viable cells by trypan blue exclusion (Fig. 2). The number of viable MV-TEC was lower than those of UV-MV-TEC and uninfected TEC, suggesting that arrest of cell growth and/or cell death occurred in MV-TEC (Fig. 2A). The absence of thymidine incorporation from the MV-TEC cultures indicated that a cell growth arrest occurred (data not shown).
We next analyzed the cell cycle distribution of infected and uninfected TEC at different time intervals from 1 to 7 days postinfection. Our results demonstrated a significant decrease of MV-TEC in the S/G2/M phases of the cell cycle from 50.1% ± 1.8% by day 1 to 21.8% ± 4% by day 7 and subsequently an accumulation in the G0/G1 phases of the cell cycle (Fig. 2B). Cell cycle arrest in the G0/G1 phases was linked to the replication of MV in TEC, since cell cycle distribution did not change during the culture of uninfected cells (data not shown) and UV-MV-TEC (remaining at between 44.9% ± 3.7% to 47.7% ± 4.4% in the S/G2/M phases) (Fig. 2B).
MV replication induced TEC differentiation.
UV-MV-TEC monolayers were highly packed and formed regular clones characteristic of typical epithelial cells in culture (Fig. 3A). Significant morphological differences in MV-TEC monolayers were observed (Fig. 3D). MV-TEC lost classical epithelial-like morphology, decreased cell-cell contacts, and acquired the squamous phenotype of highly differentiated TEC with fusiform to stellate shapes of dispersed single cells (Fig. 3D).
FIG. 3.
Differentiation of MV-TEC characterized by morphological and phenotypical changes. Left and right panels show UV-MV-TEC and MV-TEC, respectively. Phase-contrast photomicrographs of UV-MV-TEC (A) and MV-TEC (D) at day 7 postinfection. Morphology of representative TEC monolayers was documented by light microscopy (Olympus) using Hoffman optics. The photomicrographs were taken at the same original magnification (×10). Phenotypic changes were evaluated after immunostaining of low (revealed by CAM5.2 MAb at day 5 - B, E)- or high (revealed by AE3 MAb at day 7 - C, F)-molecular-weight keratins. Labeling was performed on attached UV-MV-TEC (B and C) and in MV-TEC (E and F) after cytocentrifugation. TEC were examined using an epifluorescence microscope (Axioplan 2, Zeiss; original magnification, ×63 with an oil immersion lens). Results are representative of five different experiments.
Induction of TEC differentiation by MV was examined by analyzing keratin expression in attached infected cells at days 5 and 7. Previous reports indicated that keratin isoforms are specific to epithelial stage differentiation with loss of low-molecular-weight keratin and acquisition of high-molecular-weight keratin during differentiation (13, 42). Therefore, we performed staining with either anti-CAM5.2 MAb (specific for low-molecular-weight keratin) or anti-AE3 MAb (specific for high-molecular-weight keratin) on cytospins of TEC cultures. We showed that UV-MV-TEC expressed low-molecular-weight keratin in the cytoplasm (Fig. 3B), but a lower level of high-molecular-weight keratin (Fig. 3C). In contrast, MV-TEC displayed a very low level of low-molecular-weight keratin in the cytoplasm (Fig. 3E). In addition, MV-TEC strongly expressed the high-molecular-weight keratin characteristic of differentiated cells (Fig. 3F). MV replication is required for this phenotype shift, as noninfected (data not shown) and MV-UV-TEC did not differ in the pattern of anti-keratin staining (Fig. 3B and C).
The percentage of differentiated MV-TEC was quantified by double staining with anti-NP and anti-keratin MAbs. After MV infection, 54% ± 6.6% of the floating TEC population expressing NP with a strong disappearance of low-molecular-weight keratins was fully differentiated (Fig. 4C). An intermediate state of differentiation for attached MV-TEC was observed, with a moderate expression of low-molecular-weight keratin (Fig. 4B) compared to UV-MV-TEC (Fig. 4A) and floating MV-TEC (Fig. 4C). Attached and floating MV-TEC (Fig. 4E and F) but not UV-MV-TEC (Fig. 4D) highly coexpressed high-molecular-weight keratin and NP, indicating that differentiation is associated with viral replication.
FIG. 4.
Representative flow cytometry analyses of fully differentiated floating MV-TEC. TEC were analyzed for the coexpression of NP MV and low-molecular-weight keratin (A through C) and for coexpression of NP MV and high-molecular-weight keratin (D through F). Dual fluorescence of attached UV-MV-TEC (A and D), MV-TEC (B and E) and floating MV-TEC (C and F) by day 7 postinfection are shown. Results are presented as the means of three different experiments. Quadrant limits were positioned on the negative control (not shown) for the percentages as well as the means of fluorescence intensity (MFI) determination of NP low- and NP high-molecular weight keratin coexpression, respectively. The risk of error was evaluated at the levels of P < 0.05 (*), P < 0.001 (**), or P < 0.0001 (***) in comparison with UV-MV-TEC.
MV-TEC died by apoptosis.
Trypan blue staining indicated that all floating MV-TEC were dead (data not shown). In order to understand the mechanisms of cellular death induced by MV, DNA fragmentation in attached and floating cells was evaluated. A weak degradation of genomic DNA was observed in attached MV-TEC at days 3 to 7 (Fig. 5A). A typical internucleosomal fragmentation of DNA was observed in floating MV-TEC from days 3 to 7 postinfection (Fig. 5A). In contrast, no degradation in attached controls such as uninfected TEC (data not shown) and UV-MV-TEC (Fig. 5A) was detected. These data were confirmed and expanded by the study of the nuclear morphology in attached and floating MV-TEC by Hoechst 33342 staining. Less than 10% of attached MV-TEC showed nuclear fragmentation, and these apoptotic cells were found only in syncytia (Fig. 5B). In contrast, more than 90% of floating MV-TEC showed nuclear condensation characteristic of apoptosis (Fig. 5B).
MV-induced mitochondrial swelling and hyperpolarization of attached TEC.
To further investigate the initial steps of MV-TEC apoptosis, we studied the early alterations of mitochondria by electron microscopy analysis and DIOC6(3) staining, specific for the changes in the ΔΨm (Fig. 6). Electron-microscopic observations revealed that uninfected and UV-MV-TEC contained an irregularly shaped nucleus, large bundles of cytoplasmic intermediate filaments, and numerous clustered mitochondria (data not shown). In contrast, MV-TEC showed some swelling mitochondria with an electron-dense matrix (Fig. 6B) or with a disruption of the outer membrane (Fig. 6C). Some MV-TEC presented normal mitochondria (Fig. 6A). The accumulation of DIOC6(3), measuring an increase in ΔΨm, was observed in attached MV-TEC by flow cytometry at day 7 postinfection. A consistent decrease in the ΔΨm compared to controls was detected in floating MV-TEC (Fig. 6D).
FIG. 6.
Early apoptotic process occurred in attached MV-TEC by day 7. Ultrastructure of mitochondria in MV-TEC (×35,000). Shown are normal mitochondria (A); swollen mitochondria with a dense matrix, suggesting alteration of permeability (B); and a large swollen mitochondrion with a rupture of the outer membrane (C). Scale bars, 0.5 μm. (D) DIOC6(3) fluorescence of attached and floating TEC cultures was analyzed by flow cytometry.
DISCUSSION
Mechanisms of pathogen-induced cell differentiation, particularly in the thymic epithelium, are still largely unknown. We showed here that TEC are highly susceptible to MV infection in vitro, resulting in massive viral replication and syncytium formation. These data are in agreement with previous findings based on in vitro and in vivo analyses and suggest that the thymic epithelium may be a target for MV and may indirectly provoke thymic injury by causing thymocyte depletion (3, 6, 29, 33, 45, 49). However, the alteration in cell functions induced by MV replication was not determined in these studies. We used a human cell clone derived from cortical thymic epithelium (12) to analyze a direct effect of MV on this cell type, without the potential interference and/or interaction of other cell populations present in thymic organ cultures. The present study demonstrates for the first time that MV replication in thymic epithelial cells induces terminal cell differentiation followed by apoptosis.
Consequent to MV replication, the ability of TEC to proliferate was profoundly affected, with an arrest in the G0/G1 phases of the cell cycle. An induction of growth arrest by MV was previously shown in other cell types, and various mechanisms were proposed. MV-induced impairment of uninfected peripheral blood lymphocyte proliferation did not require viral replication but was dependent on the coexpression of MV H and F glycoproteins by the MV-infected and irradiated cells (36, 38). Our study indicates that viral replication is critical for the TEC growth arrest since UV-MV, containing H and F membrane proteins, does not have any effect. However, we do not exclude the role of H and F proteins in the inhibition of TEC proliferation. Under the conditions of our study, the amount of H and F expressed early in UV-MV-TEC may be insufficient to trigger differentiation signals. In addition to H and F viral proteins, the expression of other viral protein(s) may be required as well. The role of this protein(s) remains to be elucidated.
In addition to cell growth arrest, our study demonstrates that when replicating MV, cortical thymic epithelium undergoes major changes in morphology, associated with acquisition of fusiform and stellate cellular shapes, squamous morphology, and a loss of cell-cell contacts. These findings strongly suggest that MV replication in TEC induced cell differentiation. We confirmed this observation by performing immunostaining to analyze phenotypic changes characteristic of differentiated TEC. We demonstrated that MV promotes a shift from low- to high-molecular-weight keratin expression, characteristic of differentiated epithelial cells (13, 42). This MV-induced differentiation mechanism corresponds to a progressive process correlating with the impairment of TEC growth beginning at day 3 after infection. The down-regulation of low-molecular-weight keratin expression at day 5 is followed by the acquisition of high-molecular-weight keratin and by morphological changes at day 7, ending with a complete destruction of in vitro cortical thymic epithelium layers. This observation is in agreement with previous studies demonstrating that differentiated TEC contain specific cytoskeletal proteins which are associated with late stages of epidermal keratinocyte maturation (25). However, very little is known about the cortical TEC differentiation process in vitro and in vivo. Therefore, we may hypothesize that cortical and medullary TEC could share a common TEC differentiation pathway.
MV replication in cortical TEC is required to induce the differentiation process ending with apoptosis of fully differentiated TEC in vitro. Our observation is in agreement with other studies, in which autopsies of patients with fatal measles infections demonstrated lesions in the thymus with degenerative and/or necrotic changes associated to a rapid and predominant loss of the thymic cortex (49). A marked involution of the thymic medulla was also observed, and MV antigens were found in Hassall’s corpuscles and in adjacent MV-infected thymic stromal cells (6, 29, 45, 49). We demonstrated that MV-induced apoptosis was seen in fully differentiated TEC but also in syncytia. The ability of MV to induce apoptosis has been observed in some cell lines (9), infected peripheral blood lymphocytes (1), and dendritic cells (14), as well as in T cells in contact with infected dendritic or epithelial cells (3, 14). Our data showing progressive mitochondrial swelling and disruption of the outer mitochondrial membrane indicate that differentiated MV-TEC are committed to apoptosis before they detach from matrix. These characteristics have been previously defined to be specific of early steps of apoptosis (46). In addition, late stages of apoptosis were detected in fully differentiated floating MV-TEC as well as in syncytia of attached MV-TEC. The characteristic of large syncytial multinucleated giant cells, the so-called Warthin-Finkeldey cells, resulting from fusion of more than 100 nuclei, have been described in lymphoid tissues, such as that of the thymus, during the early phase of measles (32). In addition to differentiation-induced apoptosis, it is possible that the cytopathic effect of MV leads also to apoptosis of syncytium-forming TEC.
In addition, MV replication in TEC leads to CD46 down-regulation. A correlation between CD46 internalization and in vitro susceptibility to complement-mediated lysis has been reported (37). Therefore, MV-induced CD46 down-regulation may render TEC susceptible to complement-mediated lysis, which could contribute to thymic damage observed during MV infection.
Recent reports have shown that in vivo MV infection of TEC leads to induction of thymocyte apoptosis, which may contribute to a long-term alteration of the immune system (3, 45). As thymocyte survival depends on the signal provided by stromal cells, it remains to be determined if the destruction of cortical thymic epithelium observed in vitro is induced directly, by MV replication, or indirectly, by complement-mediated lysis, and whether it could deliver abnormal signal to thymocytes and/or affects positive selection of thymocytes. As MV infection most often occurs in childhood, when the functioning of the thymus is required, defects in TEC function and survival may contribute to the immune dysfunction and to the development of immune suppression.
ACKNOWLEDGMENTS
We particularly thank J.-F. Nicolas and J. Marvel for their scientific advice during this work. We are grateful to J. Maryanski and V. Lotteau for reading the manuscript and to S. Manier, D. Gerlier, and P. Jurdic for helpful suggestions. We also thank Y. Leverrier, A. Cheff, A. Thomas-Cachard, M.-T. Nugeyre, C. Domenget, and M. Chamoux for valuable technical assistance. The useful comments of C. Servet-Delprat, A. Astier, M.-C. Trescol-Biémont, S. Guerret, and P.-O. Vidalin are greatly appreciated.
This work was supported in part by institutional grants from the Centre National de la Recherche Scientifique, the Ministère de l’Education National, de l’Enseignement Supérieur et de la Recherche, l’Institut National de la Santé et de la Recherche Médicale and by additional support from Association pour la Recherche sur le Cancer (CRC 6108) and from the Programme de Recherche sur le Vieillissement de la Région Rhône-Alpes (97-98). A.E. is a recipient of a grant from the Fondation pour la Recherche Médicale.
REFERENCES
- 1.Addae M M, Komada Y, Zhang X L, Sakurai M. Immunological unresponsiveness and apoptotic cell death of T cells in measles virus infection. Acta Paediatr Jpn. 1995;37:308–314. doi: 10.1111/j.1442-200x.1995.tb03320.x. [DOI] [PubMed] [Google Scholar]
- 2.Aldrovandi G M, Feuer G, Gao L, Jamieson B, Kristeva M, Chen I S Y, Zack J A. The SCID-hu mouse as a model for HIV-1 infection. Nature. 1993;363:732–736. doi: 10.1038/363732a0. [DOI] [PubMed] [Google Scholar]
- 3.Auwaerter P G, Kaneshima H, McCune J M, Wiegand G, Griffin D E. Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J Virol. 1996;70:3734–3740. doi: 10.1128/jvi.70.6.3734-3740.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Beckford A P, Kashula R O C, Stephan C. Factors associated with fatal cases of measles: a retrospective autopsy study. S Afr Med J. 1985;68:858–863. [PubMed] [Google Scholar]
- 5.Bonyhadi M L, Rabin L, Salimi S, Brown D A, Kosek J, McCune J M, Kaneshima H. HIV induces thymus depletion in vivo. Nature. 1993;363:728–732. doi: 10.1038/363728a0. [DOI] [PubMed] [Google Scholar]
- 6.Chino F, Kodama H, Ohkawa T, Egashira Y. Alterations of the thymus and peripheral lymphoid tissues in fatal measles. A review of 14 autopsy cases. Acta Pathol Jpn. 1979;29:493–507. doi: 10.1111/j.1440-1827.1979.tb00205.x. [DOI] [PubMed] [Google Scholar]
- 7.Coovadia H M, Parent M A, Loening W E, Wesley A, Burgess B, Hallett F, Brain P, Grace J, Naidoo J, Smythe P M, Vos G H. An evaluation of factors associated with the depression of immunity in malnutrition and in measles. Am J Clin Nutr. 1974;27:665–669. doi: 10.1093/ajcn/27.6.665. [DOI] [PubMed] [Google Scholar]
- 8.Dorig R E, Marcil A, Chopra A, Richardson C D. The human CD46 molecule is a receptor for measles virus (Edmonston strain) Cell. 1993;75:295–305. doi: 10.1016/0092-8674(93)80071-l. [DOI] [PubMed] [Google Scholar]
- 9.Esolen L M, Park S W, Hardwick J M, Griffin D E. Apoptosis as a cause of death in measles virus-infected cells. J Virol. 1995;69:3955–3958. doi: 10.1128/jvi.69.6.3955-3958.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Esolen L M, Ward B J, Moench T R, Griffin D E. Infection of monocytes during measles. J Infect Dis. 1993;168:47–52. doi: 10.1093/infdis/168.1.47. [DOI] [PubMed] [Google Scholar]
- 11.Fauci A S, Macher A M, Longo D L, Lane H C, Rook A H, Masur H, Gelmann E P. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic and therapeutic considerations. Ann Intern Med. 1983;100:92–106. doi: 10.7326/0003-4819-100-1-92. [DOI] [PubMed] [Google Scholar]
- 12.Fernandez E, Vicente A, Zapata A, Brera B, Lozano J J, Martinez C, Toribio M L. Establishment and characterization of cloned human thymic epithelial cell lines. Analysis of adhesion molecule expression and cytokine production. Blood. 1994;83:3245–3254. [PubMed] [Google Scholar]
- 13.Franke W W, Weber K, Osborn M, Schmid E, Freudenstein C. Antibody to prekeratin. Decoration of tonofilament-like arrays in various cells of epithelial character. Exp Cell Res. 1978;116:429–445. doi: 10.1016/0014-4827(78)90466-4. [DOI] [PubMed] [Google Scholar]
- 14.Fugier-Vivier I, Servet-Delprat C, Rivailler P, Rissoan M C, Liu Y J, Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with survival and functions of dendritic and T cells. J Exp Med. 1997;186:813–823. doi: 10.1084/jem.186.6.813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Galama J M D, Ubels-Postma J, Vos A, Lucas C J. Measles virus inhibits acquisition of lymphocyte functions but not established effector functions. Cell Immunol. 1980;50:401. doi: 10.1016/0008-8749(80)90294-4. [DOI] [PubMed] [Google Scholar]
- 16.Gerlier D, Varior-Krishnan G, Devaux P. CD46-mediated measles virus entry: a first key to host-range specificity. Trends Microbiol. 1995;3:338–345. doi: 10.1016/s0966-842x(00)88972-6. [DOI] [PubMed] [Google Scholar]
- 17.Giraudon P, Wild F T. Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology. 1985;144:46–58. doi: 10.1016/0042-6822(85)90303-4. [DOI] [PubMed] [Google Scholar]
- 18.Gottlieb M S, Groofman J F, Weinstein W M, Fahey J L, Detel R. The acquired immunodeficiency syndrome. Ann Intern Med. 1983;99:208–220. doi: 10.7326/0003-4819-99-2-208. [DOI] [PubMed] [Google Scholar]
- 19.Griffin D E, Ward B J, Jauregui E, Johnson R T, Vaisberg A. Natural killer cell activity during measles. Clin Exp Immunol. 1990;81:218–224. doi: 10.1111/j.1365-2249.1990.tb03321.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Grosjean I, Caux C, Bella C, Berger I, Wild F, Banchereau J, Kaiserlian D. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J Exp Med. 1997;186:801–812. doi: 10.1084/jem.186.6.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Haynes B F, Denning S M, Le P T, Singer K H. Human intrathymic T cell differentiation. Semin Immunol. 1990;2:67–77. [PubMed] [Google Scholar]
- 22.Karp C L, Wysocka M, Wahl L M, Ahearn J M, Cuomo P J, Sherry B, Trinchieri G, Griffin D E. Mechanism of suppression of cell-mediated immunity by measles virus. Science. 1996;273:228–231. doi: 10.1126/science.273.5272.228. [DOI] [PubMed] [Google Scholar]
- 23.Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne P H, Downward J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 1997;16:2783–2793. doi: 10.1093/emboj/16.10.2783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Krantic S, Gimenez C, Rabourdin-Combe C. Cell-to-cell contact via measles virus haemagglutinin-CD46 interaction triggers CD46 downregulation. J Gen Virol. 1995;76:2793–2800. doi: 10.1099/0022-1317-76-11-2793. [DOI] [PubMed] [Google Scholar]
- 25.Laster A J, Itoh T, Palker T J, Haynes B F. The human thymic microenvironment: thymic epithelium contains specific keratins associated with early and late stages of epidermal keratinocyte maturation. Differentiation. 1986;31:67–77. doi: 10.1111/j.1432-0436.1986.tb00385.x. [DOI] [PubMed] [Google Scholar]
- 26.McChesney M B, Altman A, Oldstone M B A. Suppression of T lymphocyte function by measles virus is due to cell cycle arrest in G1. J Immunol. 1988;140:1269–1273. [PubMed] [Google Scholar]
- 27.Miller D L. Frequency of complications of measles. Br Med J. 1964;2:75–78. doi: 10.1136/bmj.2.5401.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Mocarski E S, Bonyhadi M, Salimi S, McCune J M, Kaneshima H. Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication. Proc Natl Acad Sci USA. 1993;90:104–108. doi: 10.1073/pnas.90.1.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Moench T R, Griffin D E, Obriecht C R, Vaisberg A J, Johnson R T. Acute measles in patients with and without neurological involvement: distribution of measles virus antigen and RNA. J Infect Dis. 1988;158:433–442. doi: 10.1093/infdis/158.2.433. [DOI] [PubMed] [Google Scholar]
- 30.Naniche D, Varior-Krishnan G, Cervoni F, Wild T F, Rossi B, Rabourdin-Combe C, Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol. 1993;67:6025–6032. doi: 10.1128/jvi.67.10.6025-6032.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Naniche D, Wild T F, Rabourdin-Combe C, Gerlier D. A monoclonal antibody recognizes a human cell surface glycoprotein involved in measles virus binding. J Gen Virol. 1992;73:2617–2624. doi: 10.1099/0022-1317-73-10-2617. [DOI] [PubMed] [Google Scholar]
- 32.Nozawa Y, Ono N, Abe M, Sakuma H, Wakasa H. An immunohistochemical study of Warthin-Finkeldey cells in measles. Pathol Int. 1994;44:442–447. doi: 10.1111/j.1440-1827.1994.tb01708.x. [DOI] [PubMed] [Google Scholar]
- 33.Numazaki K, Goldman H, Bai X Q, Wong I, Wainberg M A. Effects of infection by HIV-1, cytomegalovirus, and human measles virus on cultured human thymic epithelial cells. Microbiol Immunol. 1989;33:733–745. doi: 10.1111/j.1348-0421.1989.tb00960.x. [DOI] [PubMed] [Google Scholar]
- 34.Rima B K, Earle J A, Yeo R P, Herlihy L, Baczko K, ter Meulen V, Carabana J, Caballero M, Celma M L, Fernandez-Munoz R. Temporal and geographical distribution of measles virus genotypes. J Gen Virol. 1995;76:1173–1180. doi: 10.1099/0022-1317-76-5-1173. [DOI] [PubMed] [Google Scholar]
- 35.Salonen R, Ilonen J, Salmi A A. Measles virus inhibits lymphocyte proliferation in vitro by two different mechanisms. Clin Exp Immunol. 1989;75:376–380. [PMC free article] [PubMed] [Google Scholar]
- 36.Schlender J, Schnorr J J, Spielhoffer P, Cathomen T, Cattaneo R, Billeter M A, ter Meulen V, Schneider-Schaulies S. Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. Proc Natl Acad Sci USA. 1996;93:13194–13199. doi: 10.1073/pnas.93.23.13194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Schneider-Schaulies J, Schnorr J J, Schlender J, Dunster L M, Schneider-Schaulies S, ter Meulen V. Receptor (CD46) modulation and complement-mediated lysis of uninfected cells after contact with measles virus-infected cells. J Virol. 1996;70:255–263. doi: 10.1128/jvi.70.1.255-263.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Schnorr J J, Seufert M, Schlender J, Borst J, Johnston I C, ter Meulen V, Schneider-Schaulies S. Cell cycle arrest rather than apoptosis is associated with measles virus contact-mediated immunosuppression in vitro. J Gen Virol. 1997;78:3217–3226. doi: 10.1099/0022-1317-78-12-3217. [DOI] [PubMed] [Google Scholar]
- 39.Schnorr J J, Xanthakos S, Keikavoussi P, Kampgen E, ter Meulen V, Schneider-Schaulies S. Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci USA. 1997;94:5326–5331. doi: 10.1073/pnas.94.10.5326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Stanley S K, McCune J M, Kaneshima H, Justement J S, Sullivan M, Boone E, Baseler M, Adelsberger J, Bonyhadi M, Orenstein J, et al. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med. 1993;178:1151–1163. doi: 10.1084/jem.178.4.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Su L, Kaneshima H, Bonyhadi M L, Salami S, Kraft D, Rabin L, McCune J M. HIV-1-induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo. Immunity. 1995;2:25–36. doi: 10.1016/1074-7613(95)90076-4. [DOI] [PubMed] [Google Scholar]
- 42.Sun T T, Eichner R, Nelson W G, Tseng S C, Weiss R A, Jarvinen M, Woodcock-Mitchell J. Keratin classes: molecular markers for different types of epithelial differentiation. J Investig Dermatol. 1983;81:109S–115S. doi: 10.1111/1523-1747.ep12540831. [DOI] [PubMed] [Google Scholar]
- 43.Tishon A, Manchester M, Scheiflinger F, Oldstone M B. A model of measles virus-induced immunosuppression: enhanced susceptibility of neonatal human PBLs. Nat Med. 1996;2:1250–1254. doi: 10.1038/nm1196-1250. [DOI] [PubMed] [Google Scholar]
- 44.Valentin H, Nugeyre M T, Vuillier F, Boumsell L, Schmid M, Barre-Sinoussi F, Pereira R A. Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro. J Virol. 1994;68:3041–3050. doi: 10.1128/jvi.68.5.3041-3050.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Valsamakis A, Schneider H, Auwaerter P G, Kaneshima H, Billeter M A, Griffin D E. Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J Virol. 1998;72:7754–7761. doi: 10.1128/jvi.72.10.7754-7761.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Vander Heiden M G, Chandel N S, Williamson E K, Schumacker P T, Thompson C B. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell. 1997;91:627–637. doi: 10.1016/s0092-8674(00)80450-x. [DOI] [PubMed] [Google Scholar]
- 47.Von Pirquet C. Das verhalten der kutanen tuberculinreaktion während der mäsern. Dtsch Med Wochenschr. 1908;30:1297–1300. [Google Scholar]
- 48.Ward B J, Johnson R T, Vaisberg A, Jauregui E, Griffin D E. Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. Clin Immunol Immunopathol. 1991;61:236–248. doi: 10.1016/s0090-1229(05)80027-3. [DOI] [PubMed] [Google Scholar]
- 49.White R G, Boyd J F. The effect of measles on the thymus and other lymphoid tissues. Clin Exp Immunol. 1973;13:343–357. [PMC free article] [PubMed] [Google Scholar]
- 50.Whittle H C, Bradley-Moore A, Fleming A, Greenwood B M. Effects of measles on the immune response of Nigerian children. Arch Dis Child. 1973;48:753–756. doi: 10.1136/adc.48.10.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere J L, Petit P X, Kroemer G. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med. 1995;181:1661–1672. doi: 10.1084/jem.181.5.1661. [DOI] [PMC free article] [PubMed] [Google Scholar]